Evidence map›Paper›PMID 40891883›Full record

ArticleMicrobiology spectrum2025

Emergence of carbapenem-resistant

Xuan Wang, Fanghua Fan, Shilei Dong, Yapei Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Molecular Epidemiology of Carbapenem-ResistantInfection and drug resistance · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xuan WangDepartment of Clinical Laboratory, Zhejiang Hospital, Hangzhou, Zhejiang, People's Republic of China.
Fanghua FanDepartment of Clinical Laboratory, Zhejiang Hospital, Hangzhou, Zhejiang, People's Republic of China.
Shilei DongDepartment of Clinical Laboratory, Zhejiang Hospital, Hangzhou, Zhejiang, People's Republic of China.ORCID 0000-0001-6344-7502
Yapei ZhangDepartment of Clinical Laboratory, Zhejiang Hospital, Hangzhou, Zhejiang, People's Republic of China.ORCID 0009-0009-0445-2315

Funding

Medical Scientific Research Foundation of Zhejiang Province, China 2023KY438Medical Scientific Research Foundation of Zhejiang Province, China 2025KY543Zhejiang Science and Technology Plan For Disease Prevention and Control 2025JK016
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacteremiabeta-LactamasesCarbapenemsSerratia InfectionsSerratia marcescensAnti-Bacterial AgentsBacterial ProteinsChinaDrug Resistance, Multiple, BacterialHumansMaleMicrobial Sensitivity TestsPlasmidsWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase NDM-1beta-LactamasesCarbapenemsblaKPC-2blaNDM-1carbapenem resistancehorizontal gene transferSerratia marcescens

Identifiers

PMID40891883
PMCPMC12502704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.